Empaveli (pegcetacoplan)

pCPA File Number: 22333

Negotiation Status:

Concluded with an LOI

Indication(s):

Paroxysmal nocturnal hemoglobinuria (PNH) in adult patients who have an inadequate response to, or are intolerant of, a C5 inhibitor

Sponsor/Manufacturer:

Sobi Canada Inc.

CDA-AMC Project Number:

SR0748-000

pCPA Engagement Letter Issued:

2023-09-08

Negotiation Process Concluded:

2024-01-17